14346-24-8,MFCD00463623
Catalog No.:AA006UWV

14346-24-8 | 5,6,7,8-Tetrahydro-3h-benzo[4,5]thieno[2,3-d]pyrimidin-4-one

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
90%
in stock  
$43.00   $30.00
- +
1g
95%
in stock  
$51.00   $36.00
- +
5g
90%
in stock  
$228.00   $159.00
- +
25g
90%
in stock  
$722.00   $505.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA006UWV
Chemical Name:
5,6,7,8-Tetrahydro-3h-benzo[4,5]thieno[2,3-d]pyrimidin-4-one
CAS Number:
14346-24-8
Molecular Formula:
C10H10N2OS
Molecular Weight:
206.2642
MDL Number:
MFCD00463623
SMILES:
Oc1ncnc2c1c1CCCCc1s2
NSC Number:
153324
Properties
Properties
 
Form:
Solid  
Storage:
Keep in dry area;Room Temperature;  

Computed Properties
 
Complexity:
292  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
0  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.9  

Downstream Synthesis Route

[1]Arya,V.P.[IndianJournalofChemistry,1972,vol.10,p.1141-1150]

[1]IndianJournalofChemistry,1972,vol.10,p.1141-1150

[1]JournalofSulfurChemistry,2013,vol.34,p.264-275

[2]Lettersindrugdesignanddiscovery,2013,vol.10,p.186-193

[3]JournalofHeterocyclicChemistry,2017,vol.54,p.3672-3681

[4]Patent:US2009/275533,2009,A1.Locationinpatent:Page/Pagecolumn39

[5]Patent:US2010/120805,2010,A1.Locationinpatent:Page/Pagecolumn42-43

[6]BioorganicChemistry,2019,vol.88

[7]BioorganicChemistry,2019

[1]EuropeanJournalofMedicinalChemistry,2019,vol.168,p.474-490

[2]Patent:WO2012/12712,2012,A2.Locationinpatent:Page/Pagecolumn48

[3]ChemMedChem,2015,vol.10,p.69-82

[4]BioorganicandMedicinalChemistryLetters,2009,vol.19,p.305-308

[1]OrientalJournalofChemistry,2014,vol.30,p.469-477

Literature

Title: Synthesis and antimicrobial activity of new substituted thienopyrimidines, their tetrazolyl and sugar derivatives.

Journal: Acta poloniae pharmaceutica 20120101

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Identification of inhibitors of checkpoint kinase 1 through template screening.

Journal: Journal of medicinal chemistry 20090813

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Parallel synthesis and biological evaluation of 5,6,7,8-tetrahydrobenzothieno[2,3-d]pyrimidin-4(3H)-one cytotoxic agents selective for p21-deficient cells.

Journal: Bioorganic & medicinal chemistry letters 20051101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Historical Records
Tags:14346-24-8 Molecular Formula|14346-24-8 MDL|14346-24-8 SMILES|14346-24-8 5,6,7,8-Tetrahydro-3h-benzo[4,5]thieno[2,3-d]pyrimidin-4-one
Catalog No.: AA006UWV
14346-24-8,MFCD00463623
14346-24-8 | 5,6,7,8-Tetrahydro-3h-benzo[4,5]thieno[2,3-d]pyrimidin-4-one
Pack Size: 250mg
Purity: 90%
in stock
$43.00 $30.00
Pack Size: 1g
Purity: 95%
in stock
$51.00 $36.00
Pack Size: 5g
Purity: 90%
in stock
$228.00 $159.00
Pack Size: 25g
Purity: 90%
in stock
$722.00 $505.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA006UWV
Chemical Name: 5,6,7,8-Tetrahydro-3h-benzo[4,5]thieno[2,3-d]pyrimidin-4-one
CAS Number: 14346-24-8
Molecular Formula: C10H10N2OS
Molecular Weight: 206.2642
MDL Number: MFCD00463623
SMILES: Oc1ncnc2c1c1CCCCc1s2
NSC Number: 153324
Properties
Form: Solid  
Storage: Keep in dry area;Room Temperature;  
Complexity: 292  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 14  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 0  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.9  
Downstream Synthesis Route
4584-49-0    14346-24-8    47046-21-9 

[1]Arya,V.P.[IndianJournalofChemistry,1972,vol.10,p.1141-1150]

26487-67-2    14346-24-8    47275-94-5 

[1]IndianJournalofChemistry,1972,vol.10,p.1141-1150

4651-91-6    64-18-6    14346-24-8 

[1]JournalofSulfurChemistry,2013,vol.34,p.264-275

[2]Lettersindrugdesignanddiscovery,2013,vol.10,p.186-193

[3]JournalofHeterocyclicChemistry,2017,vol.54,p.3672-3681

[4]Patent:US2009/275533,2009,A1.Locationinpatent:Page/Pagecolumn39

[5]Patent:US2010/120805,2010,A1.Locationinpatent:Page/Pagecolumn42-43

[6]BioorganicChemistry,2019,vol.88

[7]BioorganicChemistry,2019

77287-34-4    108354-78-5    14346-24-8 

[1]EuropeanJournalofMedicinalChemistry,2019,vol.168,p.474-490

[2]Patent:WO2012/12712,2012,A2.Locationinpatent:Page/Pagecolumn48

[3]ChemMedChem,2015,vol.10,p.69-82

[4]BioorganicandMedicinalChemistryLetters,2009,vol.19,p.305-308

77287-34-4    5936-58-3    14346-24-8 

[1]OrientalJournalofChemistry,2014,vol.30,p.469-477

Literature fold

Title: Synthesis and antimicrobial activity of new substituted thienopyrimidines, their tetrazolyl and sugar derivatives.

Journal: Acta poloniae pharmaceutica20120101

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: Identification of inhibitors of checkpoint kinase 1 through template screening.

Journal: Journal of medicinal chemistry20090813

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Title: Parallel synthesis and biological evaluation of 5,6,7,8-tetrahydrobenzothieno[2,3-d]pyrimidin-4(3H)-one cytotoxic agents selective for p21-deficient cells.

Journal: Bioorganic & medicinal chemistry letters20051101

Building Blocks More >
515162-20-6
515162-20-6
(4-[(4-Methylpiperazin-1-yl)methyl]phenyl)methylamine
AA006VK0 | MFCD08060530
51412-23-8
51412-23-8
2-(1-Phenyl-1H-pyrazol-4-yl)acetonitrile
AA006W58 | MFCD01995560
499995-82-3
499995-82-3
Boc-(s)-3-amino-3-(2,3-dichloro-phenyl)-propionic acid
AA006WQ7 | MFCD03427905
50597-62-1
50597-62-1
N-(2-CHLOROETHYL)CYCLOHEXANAMINE
AA006X9Y | MFCD18839086
239097-74-6
239097-74-6
Benzo[d]isoxazol-5-amine
AA006XQN | MFCD13190363
458-76-4
458-76-4
1,2-Bis(4-fluorophenyl)ethane
AA006YAH | MFCD00153123
223407-19-0
223407-19-0
(R)-3-Aminopyrrolidin-2-one hydrochloride
AA006YO6 | MFCD14635509
477845-12-8
477845-12-8
PIM-1 Inhibitor 2
AA006Z5E | MFCD00663768
454-93-3
454-93-3
Benzoyl chloride,3-(fluorosulfonyl)-
AA006ZIR | MFCD00062335
134792-45-3
134792-45-3
6-Fluoroisatoic anhydride
AA00701B | MFCD03300719
Submit
© 2017 AA BLOCKS, INC. All rights reserved.